Gettysburg, PA, Oct. 01, 2017 -- Effective population health management is crucial for health care providers’ future business sustainability. The movement from fee-for-service to value-based service models requires providers to identify and track patients within a larger population. Moreover, providers are increasingly compelled to report on performance measures for the specific population and receive payments based on the performance. Therefore, providers must alter their current workflows and rely on a new set of skills and activities to survive in this emerging service delivery paradigm.
Join Relias to hear from Carol Clayton, PhD, former CEO of CMT, a data analytics solution company, and Tammy Floyd, LPN/Healthcare Home Director of North Central Missouri Mental Health Center, as they talk about their journey together in supporting the evolution of the behavioral health provider system to fully functioning population health homes in the state of Missouri.
During this 60- minute executive briefing, attendees will hear:
- A framework for population health management – objectives, functionality, technology, and training
- Strategies for selecting and reporting on performance measures
- How they made population health management work at the Missouri Coalition For Behavioral Health
To learn more about this executive web briefing, or take advantage of free online registration, please visit: https://www.openminds.com/event/key-improving-population-health-management/.
All registrants will receive (at no charge and regardless of attendance) a recording of the webinar and an electronic copy of the presentation slides at its conclusion.
* * *
ABOUT Relias Learning Company
Relias Learning offers online training to post-acute care, acute care, health and human services, autism and applied behavior analysis, public safety, payers, schools, and intellectual and developmental disabilities organizations. It’s our mission to measurably improve the lives of the most vulnerable members of society and those who care for them.
ABOUT OPEN MINDS
OPEN MINDS is an award-winning information source, executive education provider, and business solutions firm specializing in the post-acute health and human service markets. For thirty years, we’ve been pioneers for change – helping organizations implement the transformational business practices they need to succeed in an evolving market with new policies and regulations.
OPEN MINDS is powered by a national team of experienced executives and subject matter experts with specific expertise in the post-acute health care market. Our mission is to improve the quality of care for individuals with complex support needs by improving the effectiveness of those serving them – provider organizations, payer and insurance organizations, government agencies, pharmaceutical organizations, and technology firms. Learn more at www.openminds.com.
OPEN MINDS Executive Education Events Team OPEN MINDS 7173341329 [email protected]


Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



